Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shelly Lynn Shields is active.

Publication


Featured researches published by Shelly Lynn Shields.


Journal of Virology | 2007

CD163 Expression Confers Susceptibility to Porcine Reproductive and Respiratory Syndrome Viruses

Jay Gregory Calvert; David Ewell Slade; Shelly Lynn Shields; Rika Jolie; Ramasamy M. Mannan; Robert G. Ankenbauer; Siao-Kun Wan Welch

ABSTRACT Direct functional screening of a cDNA expression library derived from primary porcine alveolar macrophages (PAM) revealed that CD163 is capable of conferring a porcine reproductive and respiratory syndrome virus (PRRSV)-permissive phenotype when introduced into nonpermissive cells. Transient-transfection experiments showed that full-length CD163 cDNAs from PAM, human U937 cells (histiocytic lymphoma), African green monkey kidney cells (MARC-145 and Vero), primary mouse peritoneal macrophages, and canine DH82 (histocytosis) cells encode functional virus receptors. In contrast, CD163 splice variants without the C-terminal transmembrane anchor domain do not provide PRRSV receptor function. We established several stable cell lines expressing CD163 cDNAs from pig, human, and monkey, using porcine kidney (PK 032495), feline kidney (NLFK), or baby hamster kidney (BHK-21) as the parental cell lines. These stable cell lines were susceptible to PRRSV infection and yielded high titers of progeny virus. Cell lines were phenotypically stable over 80 cell passages, and PRRSV could be serially passed at least 60 times, yielding in excess of 105 50% tissue culture infective doses/ml.


Proceedings of the National Academy of Sciences of the United States of America | 2011

Characterization of a canine homolog of hepatitis C virus

Amit Kapoor; Peter Simmonds; Gisa Gerold; Natasha Qaisar; Komal Jain; Jose A. Henriquez; Cadhla Firth; David L. Hirschberg; Charles M. Rice; Shelly Lynn Shields; W. Ian Lipkin

An estimated 3% of the worlds population is chronically infected with hepatitis C virus (HCV). Although HCV was discovered more than 20 y ago, its origin remains obscure largely because no closely related animal virus homolog has been identified; furthermore, efforts to understand HCV pathogenesis have been hampered by the absence of animal models other than chimpanzees for human disease. Here we report the identification in domestic dogs of a nonprimate hepacivirus. Comparative phylogenetic analysis of the canine hepacivirus (CHV) confirmed it to be the most genetically similar animal virus homolog of HCV. Bayesian Markov chains Monte Carlo and associated time to most recent common ancestor analyses suggest a mean recent divergence time of CHV and HCV clades within the past 500–1,000 y, well after the domestication of canines. The discovery of CHV may provide new insights into the origin and evolution of HCV and a tractable model system with which to probe the pathogenesis, prevention, and treatment of diseases caused by hepacivirus infection.


Journal of Virology | 2011

Characterization of a Canine Homolog of Human Aichivirus

Amit Kapoor; Peter Simmonds; Edward J. Dubovi; Natasha Qaisar; Jose A. Henriquez; J.L. Medina; Shelly Lynn Shields; W. I. Lipkin

ABSTRACT Many of our fatal “civilization” infectious diseases have arisen from domesticated animals. Although picornaviruses infect most mammals, infection of a companion animal is not known. Here we describe the identification and genomic characterization of the first canine picornavirus. Canine kobuvirus (CKoV), identified in stool samples from dogs with diarrhea, has a genomic organization typical of a picornavirus and encodes a 2,469-amino-acid polyprotein flanked by 5′ and 3′ untranslated regions. Comparative phylogenetic analysis using various structural and nonstructural proteins of CKoV confirmed it as the animal virus homolog most closely related to human Aichivirus (AiV). Bayesian Markov chain Monte Carlo analysis suggests a mean recent divergence time of CKoV and AiV within the past 20 to 50 years, well after the domestication of canines. The discovery of CKoV provides new insights into the origin and evolution of AiV and the species specificity and pathogenesis of kobuviruses.


Journal of General Virology | 2012

Characterization of novel canine bocaviruses and their association with respiratory disease

Amit Kapoor; Natasha Mehta; Edward J. Dubovi; Peter Simmonds; L. Govindasamy; J.L. Medina; Craig Street; Shelly Lynn Shields; W. I. Lipkin

We report the first identification, genetic characterization and disease association studies of several novel species of canine bocaviruses (CBoV). Evolutionary analysis confirmed that CBoV are genetically distinct from the only other known canine bocavirus, minute virus of canines, with which they share less than 63, 62 and 64 % protein identity in NS, NP and VP genes, respectively. Comparative genetic analysis of 37 VP gene variants found in diseased and healthy animals showed that these novel viruses are genetically highly diverse and are common in canine respiratory infections that have remained undetected until now. Interestingly, we observed that a CBoV genotype with a unique deletion in the VP2 gene was significantly more prevalent in animals with respiratory diseases compared with healthy animals.


Veterinary Microbiology | 2013

Tropism and pathological findings associated with canine respiratory coronavirus (CRCoV)

Judy A. Mitchell; Harriet W. Brooks; Balazs Szladovits; Kerstin Erles; Rachel H. Gibbons; Shelly Lynn Shields; Joe Brownlie

Abstract Canine infectious respiratory disease (CIRD) occurs frequently in densely housed dog populations. One of the common pathogens involved is canine respiratory coronavirus (CRCoV), however little is known regarding its pathogenesis and the role it plays in the development of CIRD. The pathogenesis of five geographically unrelated canine respiratory coronavirus (CRCoV) isolates was investigated. Following experimental infection in dogs, all five CRCoV isolates gave rise to clinical signs of respiratory disease consistent with that observed during natural infection. The presence of CRCoV was associated with marked histopathological changes in the nares and trachea, with loss and damage to tracheal cilia, accompanied by inflammation. Viral shedding was readily detected from the oropharynx up to 10 days post infection, but there was little or no evidence of rectal shedding. The successful re-isolation of CRCoV from a wide range of respiratory and mucosal associated lymphoid tissues, and lung lavage fluids demonstrates a clear tropism of CRCoV for respiratory tissues and fulfils the final requirement for Kochs postulates. By study day 14 dogs had seroconverted to CRCoV and the antibodies raised were neutralising against both homologous and heterologous strains of CRCoV in vitro, thus demonstrating antigenic homogeneity among CRCoV strains from the two continents. Defining the role that CRCoV and other agents play in CIRD is a considerable, but important, challenge if the disease is to be managed, treated and prevented more successfully. Here we have successfully developed a model for studying the pathogenicity and the role of CRCoV in CIRD.


Genome Announcements | 2013

Complete Genome Sequence of Mycoplasma cynos Strain C142.

Caray A. Walker; Sally A. Mannering; Shelly Lynn Shields; Damer P. Blake; Joe Brownlie

ABSTRACT Here we report the de novo genome sequencing of Mycoplasma cynos strain C142, isolated from a dog with canine infectious respiratory disease (CIRD) in the United States.


Veterinary Immunology and Immunopathology | 2004

Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates

Siao Kun W Welch; Rika Jolie; Douglas Steven Pearce; William D. Koertje; Eric Fuog; Shelly Lynn Shields; Dongwan Yoo; Jay Gregory Calvert


Archive | 2006

Vaccines and methods to treat canine influenza

Shelly Lynn Shields; Hans Draayer; Michael John Huether


Archive | 2004

Canine vaccines against Bordetella bronchiseptica

Paul Joseph Dominowski; Joseph Claude Frantz; Richard Lee Krebs; Shelly Lynn Shields; Robert Greg Sorensen


Archive | 2007

CANINE COMBINATION VACCINES

Paul Joseph Dominowski; Joseph Claude Frantz; Richard Lee Krebs; Shelly Lynn Shields; Robert Greg Sorensen

Collaboration


Dive into the Shelly Lynn Shields's collaboration.

Researchain Logo
Decentralizing Knowledge